Literature DB >> 7664179

Development of interleukin 6 and tumor necrosis factor alpha activity in nasopharyngeal secretions of infants and children during infection with respiratory syncytial virus.

K Matsuda1, H Tsutsumi, Y Okamoto, C Chiba.   

Abstract

Cytokine (interleukin 6 [IL-6] and tumor necrosis factor alpha [TNF-alpha]) activity in nasopharyngeal secretions of 21 infants and children (19 days to 16 months old) infected with primary respiratory syncytial virus was determined by an enzyme-linked immunosorbent assay. IL-6 and TNF-alpha were detectable in 100% (21 of 21) and 67% (14 of 21) of cases during the course of infection, respectively. Generally, TNF-alpha activity was high in the acute phase and declined thereafter, sometimes to undetectable levels. IL-6 activity was also highest in the acute phase and declined thereafter in infants younger than 5 months, while in patients older than 5 months, it-increased during the course of the disease to peak in the early convalescent phase. These observations suggest that inflammatory cytokines are produced in vivo in infants and children in response to primary respiratory syncytial virus infection and may be involved in disease pathogenesis. However, the mechanism of induction of cytokines may be different for infants and children in different age groups.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7664179      PMCID: PMC170153          DOI: 10.1128/cdli.2.3.322-324.1995

Source DB:  PubMed          Journal:  Clin Diagn Lab Immunol        ISSN: 1071-412X


  22 in total

Review 1.  Immunity to human and bovine respiratory syncytial virus.

Authors:  T G Kimman; F Westenbrink
Journal:  Arch Virol       Date:  1990       Impact factor: 2.574

2.  Respiratory syncytial virus epidemics: variable dominance of subgroups A and B strains among children, 1981-1986.

Authors:  M A Mufson; R B Belshe; C Orvell; E Norrby
Journal:  J Infect Dis       Date:  1988-01       Impact factor: 5.226

3.  Antigenic variation of human RSV strains isolated in Japan.

Authors:  H Tsutsumi; K Nagai; K Suga; Y Chiba; S Chiba; S Tsugawa; P L Ogra
Journal:  J Med Virol       Date:  1989-02       Impact factor: 2.327

4.  Epidemiology of respiratory syncytial virus infection in Washington, D.C. II. Infection and disease with respect to age, immunologic status, race and sex.

Authors:  R H Parrott; H W Kim; J O Arrobio; D S Hodes; B R Murphy; C D Brandt; E Camargo; R M Chanock
Journal:  Am J Epidemiol       Date:  1973-10       Impact factor: 4.897

Review 5.  Viruses and the versatile macrophage.

Authors:  P S Morahan; J R Connor; K R Leary
Journal:  Br Med Bull       Date:  1985-01       Impact factor: 4.291

6.  Productive infection of isolated human alveolar macrophages by respiratory syncytial virus.

Authors:  J R Panuska; N M Cirino; F Midulla; J E Despot; E R McFadden; Y T Huang
Journal:  J Clin Invest       Date:  1990-07       Impact factor: 14.808

7.  Respiratory syncytial virus group-specific antibody response in nasopharyngeal secretions from infants and children after primary infection.

Authors:  H Yamazaki; H Tsutsumi; K Matsuda; K Nagai; P L Ogra; S Chiba
Journal:  Clin Diagn Lab Immunol       Date:  1994-07

8.  Serum and nasal-wash immunoglobulin G and A antibody response of infants and children to respiratory syncytial virus F and G glycoproteins following primary infection.

Authors:  B R Murphy; B S Graham; G A Prince; E E Walsh; R M Chanock; D T Karzon; P F Wright
Journal:  J Clin Microbiol       Date:  1986-06       Impact factor: 5.948

9.  Tumour necrosis factors alpha and beta inhibit virus replication and synergize with interferons.

Authors:  G H Wong; D V Goeddel
Journal:  Nature       Date:  1986 Oct 30-Nov 5       Impact factor: 49.962

10.  Interleukins and IgA synthesis. Human and murine interleukin 6 induce high rate IgA secretion in IgA-committed B cells.

Authors:  K W Beagley; J H Eldridge; F Lee; H Kiyono; M P Everson; W J Koopman; T Hirano; T Kishimoto; J R McGhee
Journal:  J Exp Med       Date:  1989-06-01       Impact factor: 14.307

View more
  19 in total

1.  Respiratory syncytial virus infection of human alveolar epithelial cells enhances interferon regulatory factor 1 and interleukin-1beta-converting enzyme gene expression but does not cause apoptosis.

Authors:  R Takeuchi; H Tsutsumi; M Osaki; K Haseyama; N Mizue; S Chiba
Journal:  J Virol       Date:  1998-05       Impact factor: 5.103

Review 2.  Respiratory viral infections in hematopoietic stem cell and solid organ transplant recipients.

Authors:  S Samuel Weigt; Aric L Gregson; Jane C Deng; Joseph P Lynch; John A Belperio
Journal:  Semin Respir Crit Care Med       Date:  2011-08-19       Impact factor: 3.119

3.  Local production of inflammatory mediators during childhood parainfluenza virus infection.

Authors:  Rana E El Feghaly; Lindsay McGann; Cynthia A Bonville; Patrick J Branigan; Manika Suryadevera; Helene F Rosenberg; Joseph B Domachowske
Journal:  Pediatr Infect Dis J       Date:  2010-04       Impact factor: 2.129

Review 4.  The use of a neonatal mouse model to study respiratory syncytial virus infections.

Authors:  Stephania A Cormier; Dahui You; Srinivasa Honnegowda
Journal:  Expert Rev Anti Infect Ther       Date:  2010-12       Impact factor: 5.091

5.  Autocrine regulation and experimental modulation of interleukin-6 expression by human pulmonary epithelial cells infected with respiratory syncytial virus.

Authors:  Z Jiang; M Kunimoto; J A Patel
Journal:  J Virol       Date:  1998-03       Impact factor: 5.103

6.  Respiratory syncytial virus infection of neonatal monocytes stimulates synthesis of interferon regulatory factor 1 and interleukin-1beta (IL-1beta)-converting enzyme and secretion of IL-1beta.

Authors:  R Takeuchi; H Tsutsumi; M Osaki; S Sone; S Imai; S Chiba
Journal:  J Virol       Date:  1998-01       Impact factor: 5.103

Review 7.  Viral rhinitis.

Authors:  D A Gentile; D P Skoner
Journal:  Curr Allergy Asthma Rep       Date:  2001-05       Impact factor: 4.806

8.  The VP7 outer capsid protein of rotavirus induces polyclonal B-cell activation.

Authors:  Sarah E Blutt; Sue E Crawford; Kelly L Warfield; Dorothy E Lewis; Mary K Estes; Margaret E Conner
Journal:  J Virol       Date:  2004-07       Impact factor: 5.103

Review 9.  Respiratory syncytial virus--a comprehensive review.

Authors:  Andrea T Borchers; Christopher Chang; M Eric Gershwin; Laurel J Gershwin
Journal:  Clin Rev Allergy Immunol       Date:  2013-12       Impact factor: 8.667

Review 10.  Immunopathogenesis of polymicrobial otitis media.

Authors:  Lauren O Bakaletz
Journal:  J Leukoc Biol       Date:  2009-10-20       Impact factor: 4.962

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.